StockData
Pulse Biosciences, Inc. logo

Pulse Biosciences, Inc. (PLSE) income statement

PLSENasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$45.83+0.99 (+2.21%)

Close on Nov 18, 2026Market cap $3.27BP/E –Yield –

Pulse Biosciences, Inc. income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
0.3%
Operating margin
-7007.8%
Net margin
-6755.8%
Return on equity, FY2025
-74.4%

Financial strength

Current ratio
9.63
Debt to equity
–
Debt to assets
–
Cash to current liabilities
925.7%

Valuation

P/E ratio
–
Price to sales
2758.41
Price to book
32.85
Dividend yield
–

See a number that looks wrong?